Investing.com - Ginkgo Bioworks reported on Monday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Ginkgo Bioworks announced earnings per share of $-0.410 on revenue of $66.4M. Analysts polled by Investing.com EPS of $-0.290 on revenue of $60.35M.
Ginkgo Bioworks 's are down 81% and is trading at $2.550 , still down 81.13% from its 52 week high of $14.20 set on Tuesday, November 16, 2021.
Ginkgo Bioworks shares lost 4.85% to trade at $2.550 in after-hours trade the report.
Ginkgo Bioworks follows other major Materials sector earnings this month
Ginkgo Bioworks's report follows an earnings missed by Air Liquide ADR on Tuesday, October 25, 2022, who reported EPS of $0.5852 on revenue of $8.21B, EPS of $0.5954 on revenue of $7.46B.
Vale ADR had beat expectations on Thursday, October 27, 2022 with third quarter EPS of $0.98 on revenue of $9.93B, for EPS of $0.5594 on revenue of $10.15B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar